Lynch Regenerative Medicine, LLC., (LRM) and its wholly owned subsidiary LRM Aesthetics, Inc. (LRMA), announced today that Rob Hubert will serve as Chief Revenue Officer (CRO) across both companies, effective immediately. Hubert will report directly to Dr. Samuel Lynch, Founder and CEO of LRM.

Hubert, who has served as a Strategic Advisor to LRM and LRMA for the past 18 months, brings more than 21 years of aesthetic business experience in sales and management. He previously served as Vice President of Sales at Allergan Aesthetics.

“Rob’s depth and breadth of experience in the aesthetics market is ideal to drive continued growth for LRMA’s groundbreaking lead product, ariessence pure PDGF+™, which is one of the hottest new products in aesthetics,” said Lynch. “He will also serve a critical role in helping guide strategy for the many new aesthetic and wound-healing products under development at LRM.”

Hubert is a graduate of the United States Naval Academy who served seven years in the U.S. Navy as a Surface Warfare Officer.

About Lynch Regenerative Medicine, LLC.

Lynch Regenerative Medicine, LLC., is pioneering innovative treatments that aim to revolutionize the $100 billion aesthetics and wound-care markets. Our mission is to leverage our regenerative medicine heritage, and our decades-long commitment to safe and effective regenerative products of the highest quality, to deliver exceptional results for our customers and their patients and thereby redefine the future of aesthetic regenerative medicine. The company was founded in 2023 and is based in Franklin, Tennessee.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241120446183/en/